The landscape of dementia analysis has developed drastically with the arrival of complex biomarkers, such as amyloid PET scans, tau imaging, and blood-primarily based tests which will detect Alzheimer's pathology a long time just before signs and symptoms arise. Though these technological advancements depict impressive development in knowing neurodegenerative conditions, https://henryc209ite0.wiki-cms.com/user